IM Cannabis (IMCC) Receivables - Other (2020 - 2025)

IM Cannabis' Receivables - Other history runs 6 years deep, the most recent figure standing at $153456.5 for Q4 2025.

• On a quarterly basis, Receivables - Other fell 22.33% year-over-year to $153456.5 in Q4 2025; TTM through Dec 2025 was $153456.5, a 22.33% decrease from a year earlier, with the FY2025 full-year figure at $153456.5, down 23.88% from the prior year.
• Receivables - Other eased to $153456.5 in Q4 2025 per IMCC's latest filing, from $197574.4 in the prior quarter.
• Across five years, Receivables - Other topped out at $11.5 million in Q2 2021 and bottomed at $143657.1 in Q4 2022.
• The 5-year median for Receivables - Other is $2.8 million (2024), against an average of $4.4 million.
• Across the five-year window, Receivables - Other jumped 41506.09% in 2021 and tumbled 98.75% in 2022, its largest moves.
• Year by year, Receivables - Other stood at $11.5 million in 2021, then tumbled by 98.75% to $143657.1 in 2022, then surged by 381.14% to $691197.9 in 2023, then slumped by 71.42% to $197574.4 in 2024, then declined by 22.33% to $153456.5 in 2025.
• Per Business Quant, the three latest IMCC Receivables - Other figures stand at $153456.5 (Q4 2025), $197574.4 (Q4 2024), and $3.0 million (Q3 2024).